Literature DB >> 1018330

Hemoglobin Vancouver [alpha2beta2(73)(E17) Asp replaced by Tyr]: its structure and function.

R T Jones, B Brimhall, S Pootrakul, G Gray.   

Abstract

Hemoglobin Vancouver is a new abnormal hemoglobin with an amino acid substitution of the normal aspartyl residue 73 of the beta chain by a tyrosyl residue. It was discovered in a man of Chinese descent in association with beta thalassemia. It was subsequently detected in a sister in association with normal Hb A. The oxygen affinity of the abnormal hemoglobin is decreased but its subunit interaction is normal. The Bohr effect may be slightly increased. This is the fourth abnormal hemoglobin to be found with a substitution at beta73. The others are Hb C-Harlem (alpha2beta2 6Glu replaced by Val and 73 Asp replaced by Asn), Hb Korle-Bu (alpha2beta2 73Asp replaced by Asn), and Hb Mobile (alpha2beta2 73Asp replaced by Val). Although Hb Mobile was found in the present studies to have a decreased affinity for oxygen, Hbs C-Harlem and Korle-Bu have been reported to be normal. These observations of functional differences for variants of beta73 added to earlier observations of the role of the normal beta73 residue to the aggregation of sickle deoxyhemoglobin indicate that this position of the molecule may be important in intra as well as intermolecular interactions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1018330     DOI: 10.1007/BF01796121

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  22 in total

Review 1.  Structure and function of haemoglobin.

Authors:  J M Baldwin
Journal:  Prog Biophys Mol Biol       Date:  1975       Impact factor: 3.667

2.  A NEW METHOD FOR THE PREPARATION OF ALPHA AND BETA SUBUNITS OF HUMAN HEMOGLOBIN.

Authors:  E BUCCI; C FRONTICELLI
Journal:  J Biol Chem       Date:  1965-01       Impact factor: 5.157

3.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

4.  Sickle cell anemia a molecular disease.

Authors:  L PAULING; H A ITANO
Journal:  Science       Date:  1949-11-25       Impact factor: 47.728

5.  Differentiation of electrophoretically similar hemoglobins--such as S, D, G, and P; or A2, C, E, and O--by electrophoresis of the globin chains.

Authors:  R G Schneider
Journal:  Clin Chem       Date:  1974-09       Impact factor: 8.327

6.  Moleuclar pathology of human haemoglobin: stereochemical interpretation of abnormal oxygen affinities.

Authors:  H Morimoto; H Lehmann; M F Perutz
Journal:  Nature       Date:  1971-08-06       Impact factor: 49.962

7.  Two new hemoglobin variants with deletion. Hemoglobin tours: Thr 8 7 (F 3 ) deleted and hemoglobin St Antoine: Gly-Leu 74-75 (E 18-19 deleted. Consequences for oxygen affinity and protein stability.

Authors:  H Wajcman; D Labie; G Schapira
Journal:  Biochim Biophys Acta       Date:  1973-02-21

8.  Studies on the function of abnormal hemoglobins. I. An improved method for automatic measurement of the oxygen equilibrium curve of hemoglobin.

Authors:  K Imai; H Morimoto; M Kotani; H Watari; W Hirata
Journal:  Biochim Biophys Acta       Date:  1970-02-17

Review 9.  Some aspects of the chemistry and function of human and animal hemoglobins.

Authors:  W A Schroeder; R T Jones
Journal:  Fortschr Chem Org Naturst       Date:  1965

10.  Studies on the heterogeneity of hemoglobin. IX. The use of Tris(hydroxymethyl)aminomethanehcl buffers in the anion-exchange chromatography of hemoglobins.

Authors:  T H Huisman; A M Dozy
Journal:  J Chromatogr       Date:  1965-07
View more
  2 in total

1.  Hb Nishinomiya [Leu-Gly-inserted between codons 69(E13) and 70(E14) of beta]: a novel unstable hemoglobin with reduced oxygen affinity found in a patient with spherocytic hemolysis.

Authors:  Yoshiyuki Naito; Takayuki Takahashi; Tatsuro Matsunashi; Keiko Harano; Teruo Harano
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  Hemoglobinopathies in a hospital population in Vancouver.

Authors:  G R Gray; R B Marion
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.